{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:42:18Z","timestamp":1773960138668,"version":"3.50.1"},"reference-count":24,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Seminal vesicle invasion (SVI) as pT3b prostate cancer generally, but not uniformly, indicates poor prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To determine the clinical impact of pT3a lesions (ie, extraprostatic extension other than seminal vesicle or bladder invasion [EPE], microscopic bladder neck invasion [mBNI]), as well as unilateral (Uni) versus bilateral (Bil) SVI in pT3b disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>We assessed radical prostatectomy findings and long-term oncologic outcomes in 248 consecutive patients with pT3b disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Focal EPE, nonfocal EPE, mBNI, Uni-SVI, and Bil-SVI were identified in 13 (5.2%), 206 (83.1%), 48 (19.4%), 109 (44.0%), and 139 (56.0%) cases, respectively. Of possible combinations, we eventually divided our cases into 3 cohorts\u2014Group 1: Uni\/Bil-SVI and EPE\u2212\/mBNI\u2212 (n = 28; 11.3%); Group 2: Uni-SVI and EPE or mBNI (n = 103; 41.5%); and Group 3: Bil-SVI and EPE or mBNI (n = 70; 28.2%) or Uni\/Bil-SVI and EPE+\/mBNI+ (n = 47; 19.0%). Group 3 patients showed significant adverse histopathologic findings, compared with Group 1 or Group 2 patients. Kaplan-Meier analysis revealed that the prognosis was worse in the following order: Group 1, Group 2, and Group 3; and the differences in progression-free survival between any 2 groups were statistically significant. These significant differences were also seen in subgroups, such as those without or with adjuvant therapy before recurrence and those without lymph node metastasis. Additionally, Group 3 patients had a significantly higher risk of cancer-specific mortality than Group 2 patients. In multivariate analysis (Group 2 as a reference), Group 1 (hazard ratio [HR] = 0.169, P = .01) and Group 3 (HR = 1.620, P = .04) showed significance for progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>From these significant findings, we propose a novel pT3b subclassification, namely pT3b1 (Group 1), pT3b2 (Group 2), and pT3b3 (Group 3), which more accurately stratifies its prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0244-oa","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T10:26:48Z","timestamp":1674124008000},"page":"1261-1267","source":"Crossref","is-referenced-by-count":6,"title":["The Clinical Significance of pT3a Lesions as Well as Unilateral Versus Bilateral Invasion Into the Seminal Vesicle in Men With pT3b Prostate Cancer: A Proposal for a New pT3b Subclassification"],"prefix":"10.5858","volume":"147","author":[{"given":"Yuki","family":"Teramoto","sequence":"first","affiliation":[{"name":"From the Department of Pathology & Laboratory Medicine (Teramoto, Numbere, Wang, Miyamoto), University of Rochester Medical Center, Rochester, New York"},{"name":"James P. Wilmot Cancer Institute (Teramoto, Miyamoto), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Numbereye","family":"Numbere","sequence":"additional","affiliation":[{"name":"From the Department of Pathology & Laboratory Medicine (Teramoto, Numbere, Wang, Miyamoto), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Department of Pathology & Laboratory Medicine (Teramoto, Numbere, Wang, Miyamoto), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"From the Department of Pathology & Laboratory Medicine (Teramoto, Numbere, Wang, Miyamoto), University of Rochester Medical Center, Rochester, New York"},{"name":"James P. Wilmot Cancer Institute (Teramoto, Miyamoto), University of Rochester Medical Center, Rochester, New York"},{"name":"The Department of Urology (Miyamoto), University of Rochester Medical Center, Rochester, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"issue":"(2)","key":"2023102311050144600_i1543-2165-147-11-1261-b01","first-page":"65","article-title":"Global cancer statistic, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"(3)","key":"2023102311050144600_i1543-2165-147-11-1261-b02","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistic 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"(4)","key":"2023102311050144600_i1543-2165-147-11-1261-b03","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/bju.14237","article-title":"Guideline of guidelines: primary monotherapies for localised or locally advanced prostate cancer","volume":"122","author":"Lancee","year":"2018","journal-title":"BJU Int"},{"issue":"(2)","key":"2023102311050144600_i1543-2165-147-11-1261-b04","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: The European Association of Urology prostate cancer guidelines panel recommendations","volume":"6","author":"Van den Broeck","year":"2020","journal-title":"Eur Urol Focus"},{"key":"2023102311050144600_i1543-2165-147-11-1261-b05","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","edition":"8th ed"},{"issue":"(2)","key":"2023102311050144600_i1543-2165-147-11-1261-b06","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.juro.2008.10.033","article-title":"Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer","volume":"181","author":"Walz","year":"2009","journal-title":"J Urol"},{"issue":"(4)","key":"2023102311050144600_i1543-2165-147-11-1261-b07","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.juro.2010.06.018","article-title":"Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage","volume":"184","author":"Bud\u00e4us","year":"2010","journal-title":"J Urol"},{"issue":"(5)","key":"2023102311050144600_i1543-2165-147-11-1261-b08","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.juro.2010.12.059","article-title":"A contemporary analysis of outcomes of adenocarcinoma of the prostate with seminal vesicle invasion (pT3b) after radical prostatectomy","volume":"185","author":"Pierorazio","year":"2011","journal-title":"J Urol"},{"issue":"(2)","key":"2023102311050144600_i1543-2165-147-11-1261-b09","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0090-4295(00)00640-3","article-title":"Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters","volume":"56","author":"Epstein","year":"2000","journal-title":"Urology"},{"issue":"(6)","key":"2023102311050144600_i1543-2165-147-11-1261-b10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.urology.2008.06.055","article-title":"Prognostic significance of cancer volume involving seminal vesicles in patients with pT3bpN0 prostate cancer","volume":"72","author":"Yamamoto","year":"2008","journal-title":"Urology"},{"issue":"(7)","key":"2023102311050144600_i1543-2165-147-11-1261-b11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/his.12104","article-title":"Prognostic significance of patterns of seminal vesicle invasion in prostate cancer","volume":"62","author":"Kristiansen","year":"2013","journal-title":"Histopathology"},{"issue":"(5)","key":"2023102311050144600_i1543-2165-147-11-1261-b12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.5858\/arpa.2021-0069-OA","article-title":"The clinical impact of pT3a lesions in patients with pT3b prostate cancer undergoing radical prostatectomy: a proposal for a new pT3b subclassification","volume":"146","author":"Numbere","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"(7)","key":"2023102311050144600_i1543-2165-147-11-1261-b13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.5858\/arpa.2021-0265-OA","article-title":"The clinical impact of unilateral versus bilateral invasion into the seminal vesicle in patients with prostate cancer undergoing radical prostatectomy","volume":"146","author":"Numbere","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"(4)","key":"2023102311050144600_i1543-2165-147-11-1261-b14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"(8)","key":"2023102311050144600_i1543-2165-147-11-1261-b15","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1097\/PAS.0000000000001497","article-title":"The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on grading of prostatic carcinoma","volume":"44","author":"van Leenders","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"(1)","key":"2023102311050144600_i1543-2165-147-11-1261-b16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0022-5347(17)35415-0","article-title":"Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup","volume":"150","author":"Epstein","year":"1993","journal-title":"J Urol"},{"issue":"(9747)","key":"2023102311050144600_i1543-2165-147-11-1261-b17","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"de Bono","year":"2010","journal-title":"Lancet"},{"issue":"(3)","key":"2023102311050144600_i1543-2165-147-11-1261-b18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"(4)","key":"2023102311050144600_i1543-2165-147-11-1261-b19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"issue":"(3)","key":"2023102311050144600_i1543-2165-147-11-1261-b20","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanada","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2023102311050144600_i1543-2165-147-11-1261-b21","article-title":"The clinical significance of either extraprostatic extension or microscopic bladder neck invasion alone vs. both in men with pT3a prostate cancer undergoing radical prostatectomy [published online August 2, 2022]","author":"Teramoto","journal-title":"Am J Surg Pathol"},{"issue":"(9)","key":"2023102311050144600_i1543-2165-147-11-1261-b22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/iju.13144","article-title":"Does bilateral seminal vesicle invasion at radical prostatectomy predict worse prognosis than unilateral invasion among patients with pT3b prostate cancers?","volume":"23","author":"Lee","year":"2016","journal-title":"Int J Urol"},{"issue":"(3)","key":"2023102311050144600_i1543-2165-147-11-1261-b23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000000295","article-title":"Adjuvant and salvage radiotherapy after prostatectomy: ASTRO\/AUA guideline amendment 2018-2019","volume":"202","author":"Pisansky","year":"2019","journal-title":"J Urol"},{"issue":"(5)","key":"2023102311050144600_i1543-2165-147-11-1261-b24","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.urology.2010.08.031","article-title":"Interobserver variability in histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial","volume":"77","author":"Netto","year":"2011","journal-title":"Urology"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/11\/1261\/3279454\/i1543-2165-147-11-1261.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/11\/1261\/3279454\/i1543-2165-147-11-1261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:39:39Z","timestamp":1764790779000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/147\/11\/article-p1261.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,1,19]]},"published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0244-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,19]]}}}